78 44. 00 48. 35 63. 00 49. 61 COVID - 19 Non COVID - 19 related CT 31. 00 86. 11 77. 00 84. 62 108. 00 85. 04 COVID - 19 related CT 5. 00 13. 89 14. 00 15. 38 19. 00 14. 96 Nodule invasive exploration 25. 00 69. 44 16. 00 17. 58 41. 00 32. 28 Non metastatic disease 16. 00 44. 44 38. 00 41. 76 54. 00 41. 73 Lobectomy 8. 00 53. 33 NA NA NA NA Segmentectomy 3. 00 20. 00 NA NA NA NA Thoracic radiation 3. 00 20. 00 NA NA NA NA No treatment 1. 00 6. 67 NA NA NA NA Metastatic disease 18. 00 50. 00 35. 00 38. 46 53. 00 41. 73 Systemic therapy 15. 00 41. 67 NA NA NA NA No treatment 3. 00 8. 33 NA NA NA NA Missing 2. 00 5. 56 18 19. 78 20. 00 16. 54 Total 36. 00 100. 00 91. 00 100. 00 127. 00 100. 00 E. Grolleau, S. Couraud, E. Jupin Delevaux Respiratory Medicine and Research 86 101136 7 Acknowledgment The authors are very grateful to Thibault Thalamas ( Acute Respira - tory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre - Benite, France ) for his help in the sta - tistical analysis. Funding information This research did not receive any speciﬁc grant from funding agencies in the public, commercial, or not - for - proﬁt sectors. Supplementary materials Supplementary material associated with this article can be found in the online version at